Cash Flow Statement

Amortization Amortization Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Depreciation & Amortization (IS)EBIAT Leases Loans and Notes Receivables Long-Term Debt Issuances Long-Term Debt Repayments Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances

Ratios

Quantum Biopharma (QNTM) Shares Issued (2019 - 2025)

Quantum Biopharma's Shares Issued history spans 5 years, with the latest figure at -$43257.0 for Q4 2025.

On a quarterly basis, Shares Issued fell 102.91% to -$43257.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 83.36% decrease, with the full-year FY2024 number at $10.7 million, up 33473.35% from a year prior.
Shares Issued hit -$43257.0 in Q4 2025 for Quantum Biopharma, down from $43257.0 in the prior quarter.
Over the last five years, Shares Issued for QNTM hit a ceiling of $38.3 million in Q1 2021 and a floor of -$43257.0 in Q4 2025.
Historically, Shares Issued has averaged $4.9 million across 4 years, with a median of $169847.0 in 2024.
Biggest five-year swings in Shares Issued: soared 22067.02% in 2024 and later crashed 102.91% in 2025.
Tracing QNTM's Shares Issued over 4 years: stood at $38.3 million in 2021, then crashed by 99.92% to $31783.0 in 2023, then soared by 4573.78% to $1.5 million in 2024, then plummeted by 102.91% to -$43257.0 in 2025.
Business Quant data shows Shares Issued for QNTM at -$43257.0 in Q4 2025, $43257.0 in Q2 2025, and $1.5 million in Q4 2024.